Hubert Lee, DPM
Podiatrist · Bellevue, WANPI 1093952616
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,087 of the $1,719 with a category attached, or 63.2%. 11 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 58.5% of the total. Reporting peaked in 2019 at $930 and has fallen 71.0% since, to $270 in 2025.
Across 42 payments — averaging $40.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$1K
- Smith+Nephew$256
- Organogenesis Inc.$121
- Amgen$107
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$64
- Paratek Pharmaceuticals, Inc.$55
- plus $109 from 5 others
What the payments were for
- Travel & lodging$63237%
- Food & beverage$1,08763%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 9 | $1,006 |
| Smith+Nephew | 8 | $256 |
| Organogenesis Inc. | 6 | $121 |
| Amgen | 7 | $107 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $64 |
| Paratek Pharmaceuticals, Inc. | 3 | $55 |
| Bioventus LLC | 2 | $38 |
| Medtronic | 1 | $22 |
| Next Science LLC | 1 | $20 |
| Fusion Orthopedics USA, LLC | 1 | $17 |
| Zimmer Biomet | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$808
- Stravix$136
How this compares
$1,719 in reported general payments places this provider in the 60th percentile of 134 podiatrist providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tavaborole | 29 | $10,297 |
| Ketoconazole | 78 | $1,266 |
| Ciclopirox | 22 | $791 |
| Diclofenac Sodium | 15 | $465 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Bellevue
- Anthony MollicaBellevue$11K
- J Mari AdadBellevue$3K
- Molly IchikawaBellevue$2K
- Byron HutchinsonBurien$903K
- Michael DujelaCentralia$99K
- Huy DangCentralia$63K
- Michael FrazierFederal Way$27K
- Ryan StoneBurien$15K
- Alvin NganSeattle$13K
- Tony KimWenatchee$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.